
REEV is a technology company focused on revolutionizing mobility assistance for individuals with neurological gait disorders, such as those resulting from stroke, multiple sclerosis, or paraplegia. Their mission is to empower millions of people to overcome daily disabilities and regain autonomy through intelligent, AI-powered wearable robotics. REEV offers a two-step solution: REEV SENSE, for precise gait analysis and insights, and DREEVEN, a smart, patient-centric motorized orthosis (knee brace) that provides AI-powered assistance for walking, sitting, standing, and climbing stairs. DREEVEN is custom-made, eligible for reimbursement, and built with FDA standards in mind, aiming to restore freedom and confidence in everyday activities. The company has secured significant funding ($9.2M) and is actively collaborating with institutions like MIT for clinical studies. REEV operates with a mission-driven approach, aiming for social impact and market disruption in the orthotics industry.

REEV is a technology company focused on revolutionizing mobility assistance for individuals with neurological gait disorders, such as those resulting from stroke, multiple sclerosis, or paraplegia. Their mission is to empower millions of people to overcome daily disabilities and regain autonomy through intelligent, AI-powered wearable robotics. REEV offers a two-step solution: REEV SENSE, for precise gait analysis and insights, and DREEVEN, a smart, patient-centric motorized orthosis (knee brace) that provides AI-powered assistance for walking, sitting, standing, and climbing stairs. DREEVEN is custom-made, eligible for reimbursement, and built with FDA standards in mind, aiming to restore freedom and confidence in everyday activities. The company has secured significant funding ($9.2M) and is actively collaborating with institutions like MIT for clinical studies. REEV operates with a mission-driven approach, aiming for social impact and market disruption in the orthotics industry.
What they do: AI-powered mobility-care platform for people with neurological gait disorders.
Flagship products: REEV SENSE (wearable gait-analysis sensors/software, FDA & CE certified) and DREEVEN (AI-powered motorized knee orthosis; series expected 2026).
Latest funding: Seed round announced 2025-02-06 (~€8.8M / $9.2M).
HQ / locations: Labège / Toulouse (France) and Cambridge, MA (USA).
Mobility assistance for neurological gait disorders (stroke, multiple sclerosis, paraplegia).
2021
Medical robotics / Assistive mobility devices
€8.8M / $9.2M
Round included support from Techstars, business angels and healthcare operators; named angels included Raphaël Varane and Hervé Silbert.
“Latest round led by Newfund Heka, Polytechnique Ventures and Irdi Capital with participation from Techstars, business angels and healthcare operators (including Raphaël Varane and Hervé Silbert).”